Furthermore, there are no published trials specifically evaluating intranasal delivery of BPC-157 in humans
Mean Hounsfield unit (HU) density and lung air volume were analyzed to characterize lung health under various treatments
Interaction with dopaminergic and GABAergic systems
Most peptides degrade within minutes in biological systems, yet BPC-157 persists long enough to trigger sustained cellular responses
It resulted in nephrotoxicity documented as elevated serum blood urea nitrogen and creatinine levels, increased kidney weights, gross renal pathology changes, and an increased incidence and severity of histopathological changes in kidneys
BPC-157 Dosage Chart This BPC-157 dosage chart summarizes common community-derived research-planning ranges from ~250 mcg once daily up to ~500 mcg twice daily, with route and context shown side by side